This is going to be an iterative process and wanted to get a clean thread going because there is a lot of ground to cover and many of us are going to have different perspectives on how to approach this.
I want to thank all those offering contributions to this in advance and specifically @BrotanicalMatt for reaching out to assist.
The most effective means for effecting policy are to own the space and have broad community support. We can approach this as an industry trade organization (like many others) or we can operate as a Consensus Standards Organization for the hemp/cannabis industry. I will say that in my experience, CSOs carry more influence with regulatory bodies and facilitate freedom to operate. Youāre probably more familiar with CSOs than you think if youāve needed an ASME pressure vessel, CE, UL, or ANSI stamp on a product.
Iād really like to hear your thoughts on the following issues as we begin compiling, developing, and refining our FDA commentary.
Cultivation
Seed sales/standardsā¦ fem/non-fem, fiber, seed, cbd
Susceptibility to airborne cross pollination & pesticide crop contamination
Database of varieties currently in use & date of first useā¦ to baseline/refute/ support Plant Variety Protection Act applications.
Develop preferred GACP practices for hemp/cannabis, specifically regarding plant inspection, testing (w/ or without homogenization?), lot sizes, industry definitions (harvested, bucked, shucked, trim, flower, bud, biomass, etc.) acceptable moisture content, dockage/rejection criteria for out of spec biomass, pesticide thresholds for rejection.
Standard/boilerplate contracts/terms of sale.
Crop insurance
Bonding
Processing
High level outline of process methods currently used in industry
Outline of business practices used in industry (tolling, splits, vertical integration, spot buys)
Distinction between process intermediates sold or transferred between processers in interstate commerce and finished products for sale ā¦need guidance, data to support THC concentrations in intermediate extractsā¦ i.e. for an extract being transferred over state lines to a THC remediation processor.
Labeling of process intermediates
Acceptable solvents/levels of residual solvents
Standards for food/product contact surfaces in production equipment & cleaning protocol
Poor practices we do not reccomend
Industry support for āmany ways to skin a catā to develop a similar finished product.
Focus on flexibility (craft beer industry).
Finished products available for sale
Packaging, labeling, & testing of finished products for sale, including finished product definitions
Common Look & Feel for presenting active botanical content, active cbd content, and active thc content
Existing legal Pathways for selling finished products, including food, drugs, and/or cosmetics
Farm to table flow charts showing compliance with existing legal pathways for taking a product to market, fold or otherwise.
Disposal
Disposal pathways for spent biomass
Beneficial reuse - feed, Biofuels, etc
Municipal waste
Compost
Hazardous waste classification
Thc disposal practices
Financial Services & Safety
Consensus Standards Organizational Structure
Charter
Bylaws
Membership criteria
Board nomination/election
Board compositionā¦ all tiers (labs, breeders/genetics development, nurseries, growers, processors, retailers, consumers, researchers, financial services, regulatory, vertically integrated firms, etc)
Establishment of Collaborating Organizations Committee(regulatory agencies, medical advocacy organizations, research organizations, etc.) ā¦clearinghouse for information exchange between organizations.
FDA Hearingā¦Testimony Review
Quantitative support or rebuttal of key points/claims.
Potential answers to FDAs questions
Iāll get a doc going for this, but what are we missing in terms of topics?